PriceTargets.com logo

Inspira Technologies Oxy B.H.N. - IINN Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $13.00
  • Forecasted Upside: 884.85%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.32 As of 03/24/2023 01:00 AM ET
▼ -0.08 (-5.71%)

This chart shows the closing price for IINN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Inspira Technologies Oxy B.H.N. Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IINN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IINN

Analyst Price Target is $13.00
▲ +884.85% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Inspira Technologies Oxy B.H.N. in the last 3 months. The average price target is $13.00, with a high forecast of $13.00 and a low forecast of $13.00. The average price target represents a 884.85% upside from the last price of $1.32.

This chart shows the closing price for IINN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Inspira Technologies Oxy B.H.N..

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/25/2023AegisBoost TargetBuy$10.00 ➝ $13.00Low
11/1/2021AegisBoost TargetBuy$9.00 ➝ $10.00Low
8/26/2021AegisInitiated CoverageBuy$9.00Medium
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Inspira Technologies Oxy B.H.N. logo
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Read More

Today's Range

Now: $1.32
Low: $1.31
High: $1.40

50 Day Range

MA: $1.55
Low: $1.22
High: $1.89

52 Week Range

Now: $1.32
Low: $0.98
High: $3.18

Volume

24,075 shs

Average Volume

19,731 shs

Market Capitalization

$10.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Inspira Technologies Oxy B.H.N.?

The following Wall Street analysts have issued research reports on Inspira Technologies Oxy B.H.N. in the last twelve months: Aegis.
View the latest analyst ratings for IINN.

What is the current price target for Inspira Technologies Oxy B.H.N.?

1 Wall Street analysts have set twelve-month price targets for Inspira Technologies Oxy B.H.N. in the last year. Their average twelve-month price target is $13.00, suggesting a possible upside of 884.8%. Aegis has the highest price target set, predicting IINN will reach $13.00 in the next twelve months. Aegis has the lowest price target set, forecasting a price of $13.00 for Inspira Technologies Oxy B.H.N. in the next year.
View the latest price targets for IINN.

What is the current consensus analyst rating for Inspira Technologies Oxy B.H.N.?

Inspira Technologies Oxy B.H.N. currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IINN will outperform the market and that investors should add to their positions of Inspira Technologies Oxy B.H.N..
View the latest ratings for IINN.

What other companies compete with Inspira Technologies Oxy B.H.N.?

Other companies that are similar to Inspira Technologies Oxy B.H.N. include Nephros, NeuroMetrix, INVO Bioscience, Plus Therapeutics and InspireMD. Learn More about companies similar to Inspira Technologies Oxy B.H.N..

How do I contact Inspira Technologies Oxy B.H.N.'s investor relations team?

Inspira Technologies Oxy B.H.N.'s physical mailing address is HATIDHAR 2 11TH FLOOR, RAANANA L3, 4366504. The company's listed phone number is 972-4623-0333 and its investor relations email address is [email protected] The official website for Inspira Technologies Oxy B.H.N. is inspira-technologies.com. Learn More about contacing Inspira Technologies Oxy B.H.N. investor relations.